DELTAPHAR
ActiveSummary
The computed 12-month bankruptcy probability of DELTAPHAR is 1.7% (moderate). The 2025 annual accounts show negative equity (-€5,970) and a net result of -€15,318. Equity is shrinking by about 37% per year across the filed financial years. Its solvency ranks better than 12% of 4,978 sector peers (NACE 47, financial year 2025). The company has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
12 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
CITYPHAR
Shared director
→
DIGITALE
Shared director
→
envergure invest
Shared director
→
Europhar
Shared director
→
Show 8 more companies with a shared director
PALATINE
Shared director
→
PHARMACIE DEFRE
Shared director
→
PHARMACIE DES PAGODES
Shared director
→
PHARMACOACH
Shared director
→
PHARMADVANCE
Shared director
→
PHARMANEXT
Shared director
→
PHARMAPULSE
Shared director
→
PHARMARIVE
Shared director
→